Drug Approvals
🇺🇸 FDA Page 44FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 517–528 of 665 articles
Biosimilars Market Analysis: Impact of Recent FDA Approvals on US Pricing & Competition
SFDA Accelerated Approval Oncology: Impact on Innovative Drugs in Saudi Arabia
AstraZeneca's BREZTRI Aerosphere Approved as First Triple Therapy for Asthma in Patients 12 and Older
Vensica Medical Receives FDA IND Approval for Phase 2 Trial of ViXe Needle-Free Xeomin Delivery System
AbbVie Submits FDA Application for Upadacitinib (RINVOQ) to Treat Severe Alopecia Areata
Pharma Partnering US: $66B Deal Surge, Lilly & Sun Lead
COG 2024: Key Takeaways and Highlights from Day 1
AstraZeneca's SAPHNELO Autoinjector Approved by FDA for Self-Administration in Lupus Treatment
Cordis Launches SELUTION SLR Drug-Eluting Balloon in Japan for Peripheral Artery Disease Treatment
Jazz Pharmaceuticals' Ziihera Gets FDA Priority Review for First-Line HER2+ Cancer Treatment
FDA Grants Priority Review for IMAAVY (Nipocalimab-aahu) as First Potential Treatment for Warm Autoimmune Hemolytic Anemia
Pembrolizumab FDA Approval: Expanded Use for MSI-High Solid Tumors